Deredge Daniel, Li Jiawen, Johnson Kenneth A, Wintrode Patrick L
From the Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland 21201 and.
Department of Molecular Biosciences, Institute for Cell and Molecular Biology, University of Texas, Austin, Texas 78712.
J Biol Chem. 2016 May 6;291(19):10078-88. doi: 10.1074/jbc.M115.708370. Epub 2016 Mar 22.
New nonnucleoside analogs are being developed as part of a multi-drug regimen to treat hepatitis C viral infections. Particularly promising are inhibitors that bind to the surface of the thumb domain of the viral RNA-dependent RNA polymerase (NS5B). Numerous crystal structures have been solved showing small molecule non-nucleoside inhibitors bound to the hepatitis C viral polymerase, but these structures alone do not define the mechanism of inhibition. Our prior kinetic analysis showed that nonnucleoside inhibitors binding to thumb site-2 (NNI2) do not block initiation or elongation of RNA synthesis; rather, they block the transition from the initiation to elongation, which is thought to proceed with significant structural rearrangement of the enzyme-RNA complex. Here we have mapped the effect of three NNI2 inhibitors on the conformational dynamics of the enzyme using hydrogen/deuterium exchange kinetics. All three inhibitors rigidify an extensive allosteric network extending >40 Å from the binding site, thus providing a structural rationale for the observed disruption of the transition from distributive initiation to processive elongation. The two more potent inhibitors also suppress slow cooperative unfolding in the fingers extension-thumb interface and primer grip, which may contribute their stronger inhibition. These results establish that NNI2 inhibitors act through long range allosteric effects, reveal important conformational changes underlying normal polymerase function, and point the way to the design of more effective allosteric inhibitors that exploit this new information.
新型非核苷类似物正作为治疗丙型肝炎病毒感染的多药疗法的一部分进行研发。特别有前景的是那些与病毒RNA依赖性RNA聚合酶(NS5B)拇指结构域表面结合的抑制剂。已解析出许多晶体结构,显示小分子非核苷抑制剂与丙型肝炎病毒聚合酶结合,但仅这些结构并不能确定抑制机制。我们之前的动力学分析表明,与拇指位点2(NNI2)结合的非核苷抑制剂不会阻断RNA合成的起始或延伸;相反,它们会阻断从起始到延伸的转变,而这一转变被认为伴随着酶-RNA复合物的显著结构重排。在此,我们利用氢/氘交换动力学绘制了三种NNI2抑制剂对该酶构象动力学的影响。所有三种抑制剂都使一个从结合位点延伸超过40 Å的广泛变构网络僵化,从而为观察到的从分布式起始到持续性延伸的转变中断提供了结构依据。两种更有效的抑制剂还抑制了手指延伸-拇指界面和引物握持处的缓慢协同解折叠,这可能是它们具有更强抑制作用的原因。这些结果表明,NNI2抑制剂通过长程变构效应起作用,揭示了正常聚合酶功能背后重要的构象变化,并为利用这一新信息设计更有效的变构抑制剂指明了方向。